MPM BioImpact’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-234,478
| Closed | -$23.9M | – | 35 |
|
|
2023
Q2 | $23.9M | Buy |
234,478
+57,604
| +33% | +$5.87M | 4.81% | 5 |
|
|
2023
Q1 | $16.5M | Sell |
176,874
-17,307
| -9% | -$1.62M | 4.3% | 9 |
|
|
2022
Q4 | $7.38M | Buy |
194,181
+15,123
| +8% | +$575K | 1.91% | 16 |
|
|
2022
Q3 | $4.5M | Sell |
179,058
-942
| -0.5% | -$23.7K | 1.07% | 22 |
|
|
2022
Q2 | $5.47M | Hold |
180,000
| – | – | 1.52% | 20 |
|
|
2022
Q1 | $5.9M | Buy |
+180,000
| New | +$5.9M | 1.58% | 18 |
|